Media Coverage Of Potential Link Between Hormonal Contraception, HIV Risk Needed More ‘Critical Thinking’

In a Nature News opinion piece, James Shelton, science adviser for USAID’s Bureau for Global Health, discusses media coverage of recent findings from the journal Lancet Infectious Diseases showing that women’s use of hormonal contraception (HC) may increase the risk of HIV acquisition or transmission. “Whether HC influences HIV risk is a serious concern, and has been the subject of numerous studies. But these studies have been observational and not randomized, and thus potentially biased by who chooses to use HC,” Shelton writes. He uses “causality criteria laid down by British epidemiologist Austin Bradford Hill” to analyze the results, adding, “I find the evidence far from persuasive.”

He reviews coverage of the data presented by the study authors, comment authors, the journal and the New York Times, saying that these actors presented “little critical thinking” in their reviews. Shelton concludes that the possible relationship between HC and HIV acquisition and transmission “remains a complicated and serious issue,” and “[w]e deserve better [reporting], from all involved” (11/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.